Affirmation of NY N351915; Tariff classification of Polyethylene Glycol (PEG) 3350 USP (CAS # 25322-68-3)
No Headquarters ruling in this index revokes or modifies this ruling. That is not confirmation that it is still in effect: this index does not hold every Headquarters ruling. Confirm its current status with CBP before relying on it (ruling on CBP CROSS). Text last read from CBP on Nov 21, 2026.
Ruling text
This letter is in response to your correspondence, dated January 13, 2026, in which you request reconsideration of New York Ruling Letter (NY) N351915, dated August 13, 2025 (reconsideration request). NY N351915, which was issued to you on behalf of Hampton Pharma LLC (Hampton), involves the tariff classification of Polyethylene Glycol (PEG) 3350 USP1 (PEG 3350) (CAS # 25322-68-3), under the Harmonized Tariff Schedule of the United States (HTSUS).
In NY N351915, U.S. Customs and Border Protection (CBP) classified the subject product under subheading 3907.29.00, HTSUS, which provides for “[p]olyacetals, other polyethers and epoxide resins, in primary forms; polycarbonates, alkyd resins, polyallyl esters and other polyesters, in primary forms: other polyethers: other.” In your reconsideration request, you assert that the classification is incorrect because: the high purity, USP grade, and dedicated function of the product as a specific chemical compound and Active Pharmaceutical Ingredient (API) mandate its classification within Section VI, Chapter 29 (Organic Chemicals).
You further assert and that the PEG 3350 is correctly classifiable in heading 2909, HTSUS, which provides for “[e]thers, ether-alcohols, ether-phenols, ether-alcohol- phenols, alcohol peroxides, ether peroxides, acetal and hemiacetal peroxides, ketone peroxides (whether or not chemically defined), and their halogenated, sulfonated, nitrated or nitrosated derivatives.” 1 NY N351915 transposed the numerical reference as 3550 - 3350 is the actual number. 2 Alternatively, if not classified in heading 2909, HTSUS, you assert the subject merchandise is classifiable in heading 3004, HTSUS which provides for “[m]edicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.” To support your argument, you cite to Headquarters Ruling (HQ) Letter 962562, dated July 10, 2000, and NY N342461, dated September 18, 2004.
Having reviewed NY N351915 and determined that it is correct, we hereby affirm NY N351915 for the reasons set forth below. The product at issue was described in NY N351915, as follows: The product under consideration is Polyethylene Glycol (PEG) 3350 CAS# 25322-68-3. The product is a white granular powder and will be imported in bulk. It is noted to be pharmaceutical grade and is intended for sale to pharmaceutical manufacturers for further processing.
The descriptions of the PEG 3350 included in your reconsideration request further state that the product is a high-purity active pharmaceutical ingredient (API) that contains a separate chemically defined compound engineered for osmotic laxative applications and has a narrow molecular weight distribution. Classification under the HTSUS is in accordance with the General Rules of Interpretation (GRIs).
GRI 1 provides that the classification of goods will be determined according to the terms of the headings of the tariff schedule and any relative section or chapter notes.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (H356809).